Literature DB >> 9257751

The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.

W J Munckhof1, D Olden, J D Turnidge.   

Abstract

The postantibiotic effect (PAE) of imipenem against Escherichia coli was measured at a wide variety of drug concentrations and times of exposure. We observed that the area under the concentration-time curve of drug exposure (AUC), the product of time of exposure and concentration of drug, is a much better predictor of the duration of the PAE than either parameter alone. We also measured the PAE of imipenem against strains of gram-positive and gram-negative bacteria for which MICs varied widely. The E50, the AUC required to produce 50% of the maximum PAE, is correlated with the MIC and is independent of species. This may explain why the duration of the PAE differs for bacteria of the same species for which MICs are different.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257751      PMCID: PMC163995     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Evaluation of the E test, a novel method of quantifying antimicrobial activity.

Authors:  D F Brown; L Brown
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

Review 2.  Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations.

Authors:  J D Turnidge
Journal:  Scand J Infect Dis Suppl       Date:  1990

3.  Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.

Authors:  B Kuenzi; C Segessenmann; A U Gerber
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

4.  Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.

Authors:  B Vogelman; S Gudmundsson; J Leggett; J Turnidge; S Ebert; W A Craig
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

5.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

6.  Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.

Authors:  H Hanberger; L E Nilsson; R Maller; M Nilsson
Journal:  Scand J Infect Dis Suppl       Date:  1990

7.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

8.  Postantibiotic effect of imipenem on Pseudomonas aeruginosa.

Authors:  C I Bustamante; G L Drusano; B A Tatem; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.

Authors:  J E Leggett; B Fantin; S Ebert; K Totsuka; B Vogelman; W Calame; H Mattie; W A Craig
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

10.  Ampicillin susceptibility and ampicillin-induced killing rate of Escherichia coli.

Authors:  I P Thonus; P Fontijne; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

  10 in total
  6 in total

1.  Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004.

Authors:  W J Munckhof; G Borlace; J D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  J Li; J Turnidge; R Milne; R L Nation; K Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 3.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

4.  Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.

Authors:  Marzia Dolcino; Alberto Zoratti; Eugenio A Debbia; Gian Carlo Schito; Anna Marchese
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 5.  Ertapenem: a review of its use in the management of bacterial infections.

Authors:  Monique Curran; Dene Simpson; Caroline Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.

Authors:  Alasdair P MacGowan; Karen E Bowker; Alan R Noel
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.